532P Phase Ib Study Evaluating BI 836880 (vegf/ang2 Nanobody) in Combination with Ezabenlimab (BI 754091; Anti-Pd-1 Antibody) in Patients with Solid Tumours
Annals of Oncology(2021)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined